28986461|t|GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
28986461|a|Neurodegenerative proteinopathies characterized by intracellular aggregates of tau proteins, termed tauopathies, include Alzheimer's disease (AD), frontotemporal lobar degeneration (FTLD) with tau pathology (FTLD-tau), and related disorders. Pathological tau proteins derived from human AD brains (AD-tau) act as proteopathic seeds that initiate the templated aggregation of soluble tau upon intracerebral injection into tau transgenic (Tg) and wild-type mice, thereby modeling human tau pathology. In this study, we found that aged Tg mice of both sexes expressing human tau proteins harboring a pathogenic P301L MAPT mutation labeled with green fluorescent protein (T40PL-GFP Tg mouse line) exhibited hyperphosphorylated tau mislocalized to the somatodentritic domain of neurons, but these mice did not develop de novo insoluble tau aggregates, which are characteristic of human AD and related tauopathies. However, intracerebral injections of either T40PL preformed fibrils (PFFs) or AD-tau seeds into T40PL-GFP mice induced abundant intraneuronal pathological inclusions of hyperphosphorylated T40PL-GFP. These injections of pathological tau resulted in the propagation of tau pathology from the injection site to neuroanatomically connected brain regions, and these tau inclusions consisted of both T40PL-GFP and WT endogenous mouse tau. Primary neurons cultured from the brains of neonatal T40PL-GFP mice provided an informative in vitro model for examining the uptake and localization of tau PFFs. These findings demonstrate the seeded aggregation of T40PL-GFP in vivo by synthetic PFFs and human AD-tau and the utility of this system to study the neuropathological spread of tau aggregates.SIGNIFICANCE STATEMENT The stereotypical spread of pathological tau protein aggregates have recently been attributed to the transmission of proteopathic seeds. Despite the extensive use of transgenic mouse models to investigate the propagation of tau pathology in vivo, details of the aggregation process such as the early seeding events leading to new tau pathology have remained elusive. This study validates the use of GFP-labeled tau expressed by neurons in vivo and in vitro as models for investigating mechanisms underlying the seeded transmission of tau pathology as well as tau-focused drug discovery to identify disease-modifying therapies for AD and related tauopathies.
28986461	11	16	Human	Species	9606
28986461	17	20	Tau	Gene	4137
28986461	32	36	Mice	Species	10090
28986461	45	54	Tauopathy	Disease	MESH:D024801
28986461	83	94	Alzheimer's	Disease	MESH:D000544
28986461	122	125	Tau	Gene	4137
28986461	146	151	Human	Species	9606
28986461	152	155	Tau	Gene	4137
28986461	165	198	Neurodegenerative proteinopathies	Disease	MESH:D019636
28986461	244	247	tau	Gene	4137
28986461	265	276	tauopathies	Disease	MESH:D024801
28986461	286	305	Alzheimer's disease	Disease	MESH:D000544
28986461	307	309	AD	Disease	MESH:D000544
28986461	312	345	frontotemporal lobar degeneration	Disease	MESH:D057174
28986461	347	351	FTLD	Disease	MESH:D057174
28986461	358	361	tau	Gene	4137
28986461	373	381	FTLD-tau	Disease	MESH:D057174
28986461	420	423	tau	Gene	4137
28986461	446	451	human	Species	9606
28986461	452	454	AD	Disease	MESH:D000544
28986461	463	465	AD	Disease	MESH:D000544
28986461	466	469	tau	Gene	4137
28986461	548	551	tau	Gene	4137
28986461	586	589	tau	Gene	4137
28986461	620	624	mice	Species	10090
28986461	643	648	human	Species	9606
28986461	649	652	tau	Gene	4137
28986461	701	705	mice	Species	10090
28986461	731	736	human	Species	9606
28986461	737	740	tau	Gene	4137
28986461	773	778	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;CorrespondingGene:4137;RS#:63751273;CorrespondingSpecies:9606;CA#:225444
28986461	779	783	MAPT	Gene	4137
28986461	846	851	mouse	Species	10090
28986461	888	891	tau	Gene	4137
28986461	957	961	mice	Species	10090
28986461	996	999	tau	Gene	4137
28986461	1040	1045	human	Species	9606
28986461	1046	1048	AD	Disease	MESH:D000544
28986461	1061	1072	tauopathies	Disease	MESH:D024801
28986461	1152	1154	AD	Disease	MESH:D000544
28986461	1155	1158	tau	Gene	4137
28986461	1180	1184	mice	Species	10090
28986461	1307	1310	tau	Gene	4137
28986461	1342	1345	tau	Gene	4137
28986461	1436	1439	tau	Gene	4137
28986461	1497	1502	mouse	Species	10090
28986461	1503	1506	tau	Gene	4137
28986461	1571	1575	mice	Species	10090
28986461	1660	1663	tau	Gene	4137
28986461	1763	1768	human	Species	9606
28986461	1769	1771	AD	Disease	MESH:D000544
28986461	1772	1775	tau	Gene	4137
28986461	1848	1851	tau	Gene	4137
28986461	1927	1930	tau	Gene	4137
28986461	2063	2068	mouse	Species	10090
28986461	2110	2113	tau	Gene	4137
28986461	2216	2219	tau	Gene	4137
28986461	2297	2300	tau	Gene	4137
28986461	2420	2423	tau	Gene	4137
28986461	2445	2448	tau	Gene	4137
28986461	2516	2518	AD	Disease	MESH:D000544
28986461	2531	2542	tauopathies	Disease	MESH:D024801
28986461	Association	MESH:D024801	4137
28986461	Association	MESH:D057174	4137
28986461	Association	MESH:D000544	4137

